Drugs / Huaiqihuang granules
Huaiqihuang granules
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04263922 | Jun 2020 → Oct 2025 | chronic kidney disease | The First Affiliated Hospital of Dalian Medical University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04623866 Comparator | Nov 2020 → Aug 2021 | immunoglobulin A vasculitis | The Children's Hospital of Zhejiang University School of Medicine | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Huaiqihuang granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04263922 ↗ |
| Known as | huaiqihuang | “Studies have shown that huaiqihuang treatment can reduce cytokines in children with purpura nephritis” NCT04623866 ↗ |
| Known as | Huaiqinhuang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04623866 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Huaiqihuang Granule is a kind of Chinese herbal medicine compound preparation” NCT04263922 ↗ |
| Route | Oral | “Oral administration.” NCT04263922 ↗ |